Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Clinical Oncology
|
June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections
Weijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Cancer
|
June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
Meera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Blood Advances
|
January 4, 2018
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
Zimu Gong, L Jeffrey Medeiros, Jorge E Cortes, et al.
Annals of Hematology
|
July 8, 2023
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Ethan A Burns, Justin J Wilson, Sunil Mathur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 17, 2018
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome
Habibe Kurt, Lan Zheng, Hagop M Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma
Suyang Hao, Xinyan Lu, Zimu Gong, et al.
Cancer
|
October 16, 2018
Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value
Juliana E Hidalgo-Lόpez, Rashmi Kanagal-Shamanna, Andrés E Quesada, et al.
American Journal of Hematology
|
March 12, 2025
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation
Rohtesh S Mehta, Hannah Choe, Jennifer Saultz, et al.
Cancers
|
January 8, 2023
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Ethan A Burns, Kelly Gee, Ryan B Kieser, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
American Journal of Clinical Oncology
|
June 9, 2021
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections
Weijie Ma, Zimu Gong, Hamzah Abu-Sbeih, et al.
Cancer
|
June 7, 2023
Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma
Meera Mohan, Zimu Gong, Timothy Cody Ashby, et al.
Blood Advances
|
January 4, 2018
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy
Zimu Gong, L Jeffrey Medeiros, Jorge E Cortes, et al.
Annals of Hematology
|
July 8, 2023
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry
Ethan A Burns, Justin J Wilson, Sunil Mathur, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 17, 2018
Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome
Habibe Kurt, Lan Zheng, Hagop M Kantarjian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 10, 2020
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma
Suyang Hao, Xinyan Lu, Zimu Gong, et al.
Cancer
|
October 16, 2018
Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value
Juliana E Hidalgo-Lόpez, Rashmi Kanagal-Shamanna, Andrés E Quesada, et al.
American Journal of Hematology
|
March 12, 2025
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation
Rohtesh S Mehta, Hannah Choe, Jennifer Saultz, et al.
Cancers
|
January 8, 2023
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Ethan A Burns, Kelly Gee, Ryan B Kieser, et al.
Page
of 2